StockData
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) stock

AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.96−0.16 (-3.88%)

Close on Nov 17, 2026Market cap $317.61MP/E –Yield –

Atea Pharmaceuticals r&d expenses

Research and development expenses are spending on new products and technology.

Atea Pharmaceuticals's R&D Expenses for the twelve months ending Jun 30, 2026 was $155.45M, up 36.7% year over year. For fiscal 2025 it was $148.02M, up 2.7% from the year before. The highest annual figure on record is $167.21M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$148.02M+2.7%
FY2024Dec 31, 2024$144.10M+26.1%
FY2023Dec 31, 2023$114.24M+39.4%
FY2022Dec 31, 2022$81.94M-51.0%
FY2021Dec 31, 2021$167.21M+339.7%
FY2020Dec 31, 2020$38.02M+273.9%
FY2019Dec 31, 2019$10.17M+52.4%
FY2018Dec 31, 2018$6.68M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$28.15M-12.8%
Q1 FY2026Mar 31, 2026$41.13M+39.0%
Q4 FY2025Dec 31, 2025$47.82M+86.3%
Q3 FY2025Sep 30, 2025$38.35M+46.6%
Q2 FY2025Jun 30, 2025$32.28M-7.0%
Q1 FY2025Mar 31, 2025$29.58M-48.6%
Q4 FY2024Dec 31, 2024$25.67M-26.7%
Q3 FY2024Sep 30, 2024$26.16M-7.2%
Q2 FY2024Jun 30, 2024$34.70M+57.3%
Q1 FY2024Mar 31, 2024$57.58M+98.8%
Q4 FY2023Dec 31, 2023$35.05M+27.3%
Q3 FY2023Sep 30, 2023$28.18M+474.5%
Q2 FY2023Jun 30, 2023$22.06M+11.1%
Q1 FY2023Mar 31, 2023$28.95M-2.3%
Q4 FY2022Dec 31, 2022$27.54M-52.4%
Q3 FY2022Sep 30, 2022$4.91M-88.6%
Q2 FY2022Jun 30, 2022$19.86M-50.1%
Q1 FY2022Mar 31, 2022$29.63M+11.5%
Q4 FY2021Dec 31, 2021$57.81M+317.5%
Q3 FY2021Sep 30, 2021$43.02M+216.3%
Q2 FY2021Jun 30, 2021$39.80M+413.3%
Q1 FY2021Mar 31, 2021$26.57M+841.9%
Q4 FY2020Dec 31, 2020$13.85M+296.8%
Q3 FY2020Sep 30, 2020$13.60M+464.1%
Q2 FY2020Jun 30, 2020$7.76M–
Q1 FY2020Mar 31, 2020$2.82M–
Q4 FY2019Dec 31, 2019$3.49M–
Q3 FY2019Sep 30, 2019$2.41M–

More Atea Pharmaceuticals figures

See a number that looks wrong?